Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Erin Wright has maintained an Underweight rating on PetMed Express (NASDAQ:PETS) and lowered the price target from $10 to $7.
October 31, 2023 | 12:41 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an Underweight rating on PetMed Express and lowered the price target from $10 to $7.
The lowered price target from Morgan Stanley indicates a bearish outlook for PetMed Express. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100